T. Doran

发表

Immunological and Molecular Analysis of the Sentinel Lymph Node: A Potential Approach to Predict Outcome, Tailor Therapy, and Optimize Parameters for Tumor Vaccine Development

R. Puri, B. Fox, S. Meijer, 2001, Journal of clinical pharmacology.

Immunological and Molecular Analysis of the Sentinel Lymph Node: A Potential Approach to Predict Outcome, Tailor Therapy, and Optimize Parameters for Tumor Vaccine Development

R. Puri, B. Fox, S. Meijer, 2001 .

Adjuvant immunization of HLA-A2-positive melanoma patients with a modified gp100 peptide induces peptide-specific CD8+ T-cell responses.

W. Alvord, B. Fox, H. Maecker, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Expression of somatostatin receptor subtype 1-5 genes in human pancreatic cancer.

L. Boros, W. Fisher, W. Schirmer, 1998, Journal of the National Cancer Institute.

Immunological and Molecular Analysis of the Sentinel Lymph Node: A Potential Approach to Predict Outcome, Tailor Therapy, and Optimize Parameters for Tumor Vaccine Development

R. Puri, B. Fox, S. Meijer, 2001 .

Immunization of metastatic breast cancer patients with CD80-modified breast cancer cells and GM-CSF.

W. Urba, W. Wood, J. Smith, 1998, Advances in experimental medicine and biology.

Adoptive Cellular Therapy With Tumor Vaccine Draining Lymph Node Lymphocytes After Vaccination With HLA-B7/&bgr;2-Microglobulin Gene-Modified Autologous Tumor Cells

W. Alvord, B. Fox, S. Meijer, 2002, Journal of immunotherapy.

Expression of the somatostatin receptor subtype-2 gene predicts response of human pancreatic cancer to octreotide.

W. Fisher, C. Sabourin, W. Schirmer, 1996, Surgery.

Immune Effects of Escalating Doses of Granulocyte-Macrophage Colony-Stimulating Factor Added to a Fixed, Low-Dose, Inpatient Interleukin-2 Regimen: A Randomized Phase I Trial in Patients With Metastatic Melanoma and Renal Cell Carcinoma

W. Alvord, W. Urba, J. W. Smith, 2003, Journal of immunotherapy.

Vaccination of women with metastatic breast cancer, using a costimulatory gene (CD80)-modified, HLA-A2-matched, allogeneic, breast cancer cell line: clinical and immunological results.

W. Alvord, B. Fox, S. Meijer, 2003, Human gene therapy.

Examining the immune response in sentinel lymph nodes of mice and men

R. Puri, B. Fox, W. Urba, 1999, European Journal of Nuclear Medicine.